| Dr Leo Peter Langlois, MD | |
|
230 S. Montclair St Ste 101, Bakersfield, CA 93309 | |
| (661) 326-8035 | |
| (661) 326-8037 |
| Full Name | Dr Leo Peter Langlois |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 31 Years |
| Location | 230 S. Montclair St Ste 101, Bakersfield, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912925074 | NPI | - | NPPES |
| 56-2375861 | Other | CA | TAX ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | G86015 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital | Bakersfield, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Langlois Medical Corporation | 1557255932 | 2 |
News Archive
A special artificial intelligence (AI)-based computer algorithm created by Mount Sinai researchers was able to learn how to identify subtle changes in electrocardiograms (also known as ECGs or EKGs) to predict whether a patient was experiencing heart failure.
A team of researchers has developed a portable detection system that can rapidly identify some of the most virulent, often multi-drug resistant pathogens.
Scientists from Bern have discovered a mechanism which is responsible for the degeneration of Purkinje cells in the cerebellum in a neurodegenerative disease called Spinocerebellar ataxia type 1. The results of their study open up new avenues for the future treatment of cerebellum associated degenerative disorders.
New research finds that a protein that is often mutated in Huntington's disease (HD) plays an unexpected role in the process of neurogenesis. The research, published by Cell Press in the August 12 issue of the journal Neuron, provides new insight into HD pathology and has even broader implications for human health and disease.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that encouraging preliminary results of a Phase 2 trial of ganetespib as a single agent in non-small cell lung cancer were presented at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
› Verified 6 days ago
| Entity Name | Langlois Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043343247 PECOS PAC ID: 1557255932 Enrollment ID: O20040209000751 |
News Archive
A special artificial intelligence (AI)-based computer algorithm created by Mount Sinai researchers was able to learn how to identify subtle changes in electrocardiograms (also known as ECGs or EKGs) to predict whether a patient was experiencing heart failure.
A team of researchers has developed a portable detection system that can rapidly identify some of the most virulent, often multi-drug resistant pathogens.
Scientists from Bern have discovered a mechanism which is responsible for the degeneration of Purkinje cells in the cerebellum in a neurodegenerative disease called Spinocerebellar ataxia type 1. The results of their study open up new avenues for the future treatment of cerebellum associated degenerative disorders.
New research finds that a protein that is often mutated in Huntington's disease (HD) plays an unexpected role in the process of neurogenesis. The research, published by Cell Press in the August 12 issue of the journal Neuron, provides new insight into HD pathology and has even broader implications for human health and disease.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that encouraging preliminary results of a Phase 2 trial of ganetespib as a single agent in non-small cell lung cancer were presented at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leo Peter Langlois, MD Po Box 22710, Bakersfield, CA 93390-2710 Ph: (661) 900-4856 | Dr Leo Peter Langlois, MD 230 S. Montclair St Ste 101, Bakersfield, CA 93309 Ph: (661) 326-8035 |
News Archive
A special artificial intelligence (AI)-based computer algorithm created by Mount Sinai researchers was able to learn how to identify subtle changes in electrocardiograms (also known as ECGs or EKGs) to predict whether a patient was experiencing heart failure.
A team of researchers has developed a portable detection system that can rapidly identify some of the most virulent, often multi-drug resistant pathogens.
Scientists from Bern have discovered a mechanism which is responsible for the degeneration of Purkinje cells in the cerebellum in a neurodegenerative disease called Spinocerebellar ataxia type 1. The results of their study open up new avenues for the future treatment of cerebellum associated degenerative disorders.
New research finds that a protein that is often mutated in Huntington's disease (HD) plays an unexpected role in the process of neurogenesis. The research, published by Cell Press in the August 12 issue of the journal Neuron, provides new insight into HD pathology and has even broader implications for human health and disease.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that encouraging preliminary results of a Phase 2 trial of ganetespib as a single agent in non-small cell lung cancer were presented at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
› Verified 6 days ago
Brian Knutson, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2838 Oswell St, Bakersfield, CA 93306 Phone: 661-377-1700 | |
Julie Marie Contos, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3850 Riverlakes Dr, Bakersfield, CA 93312 Phone: 661-529-5303 | |
Fernando Garcia-rodriguez, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1801 Oak St, Bakersfield, CA 93301 Phone: 661-327-9800 | |
Jay H. Yoo, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 5251 Office Park Dr., Blgd. 100 Ste. 120, Bakersfield, CA 93309 Phone: 661-336-0700 Fax: 661-336-0200 | |
Alan Inocentes, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3733 San Dimas St, Bakersfield, CA 93301 Phone: 800-353-5400 | |
Tara Schulze, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1820 Chester Ave, Bakersfield, CA 93301 Phone: 661-631-8793 | |
Chris Sung-il Yoon, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 5001 Commerce Dr, Suite #100, Bakersfield, CA 93309 Phone: 661-325-8375 Fax: 661-633-3799 |